etanercept pregnancy category B2 small Australia Au small , B small United States U.S. small legal ... S 36 molecular weight 51234.9 g mol Etanercept trade name Enbrel is a drug that treats autoimmune ... data 78003 000119312511048877 dex13.htm Sales reached 3b in 2010 ref Etanercept is a fusion protein ... produces a continuous protein fusing TNF receptor 2 to IgG1. Production of Etanercept is accomplished ... spondylitis treated with etanercept 50 mg once weekly and 25 mg twice weekly journal Rheumatology ... work ref In North America, etanercept is co marketed by Amgen and Pfizer under the trade name Enbrel ... the drug. Etanercept is an example of a protein based drug created using the tools of biotechnology and conceived through an understanding afforded by modern cell biology . Development Etanercept was developed ... for clinical use. Etanercept is a protein dimer dimeric molecule , ref name pmid11712048 cite journal ... which initiate and amplify inflammation. Inhibition of its action by etanercept reduces the inflammatory ... cells red blood cells, which are not nucleated, do not contain TNF receptors on their surface . Etanercept ... being that etanercept, because it is a fusion protein rather than a simple TNF receptor, has a greatly ... S, Muthuramalingam SR, Braybrooke JP, et al. title Study of etanercept, a tumor necrosis factor ... 23 25 5950 ref Structure Etanercept is made from the combination of two naturally occurring soluble ... these three agents etanercept, infliximab and adalimumab are all biologic anti TNF therapeutics, their methods ... route of administration. On May 2, 2008, the FDA placed a black box warning on etanercept due to a number ... label uses Given the central role of TNF alpha in many diseases, etanercept is being studied as treatment ... , in which it was not effective . ref cite journal author title Etanercept plus standard therapy ... Wegener s Granulomatosis Etanercept Trial WGET Research Group ref Alzheimer s disease A 2006 pilot ... s disease AD after treatment with etanercept. ref name pmid16926764 cite journal author ... more details
s disease following perispinal administration of etanercept ref http www.jneuroinflammation.com ... following perispinal etanercept administration Bot generated title ref which has been received ... 5 1 3 Journal of Neuroinflammation Full text Perispinal etanercept Potential as an Alzheimer therapeutic ... 2011, begun enrollment into a randomized, placebo controlled clinical trial of etanercept for patients ... of epidural etanercept for sciatica U.S. patent 6,419,944 issued to Tobinick July 2002 , for which ... the Tumor necrosis factors TNF receptor fusion protein etanercept , for the treatment of certain neurologic ... utility of etanercept , alone or in combination with oseltamivir for treatment of influenza U.S. patent ... of chronic stroke deficits after perispinal etanercept three consecutive cases. journal CNS Drugs ... Tobinick E title Perispinal etanercept a new therapeutic paradigm in neurology journal Expert Review ... X. title Rapid intracerebroventricular delivery of Cu DOTA etanercept after peripheral administration ... cite journal doi 10.1016 j.drudis.2008.10.005 author Tobinick Edward title Perispinal etanercept ... 3 4 pmid 19027875 cite journal author Tobinick Edward title Perispinal Etanercept Produces Rapid ... in verbal fluency and aphasia following perispinal etanercept in Alzheimer s disease journal ..., Gross H. title Rapid cognitive improvement in Alzheimer s disease following perispinal etanercept administration ... title Perispinal etanercept for treatment of Alzheimer s disease journal Current Alzheimer Research ... last2 Vega first2 CP cite journal author Tobinick E, Davoodifar S. title Efficacy of etanercept delivered ... Targeted etanercept for discogenic neck pain Uncontrolled, open label results in two adults year 2003 ... Targeted etanercept for treatment refractory pain due to bone metastasis two case reports journal ... more details
of ABT 874 vs Placebo in Subjects With Active Crohn s Disease ref Briakinumab was compared to etanercept ..., 40 56 under etanercept, and 7 under placebo reached PASI reduction of at least 75 . ref http www.abbott.com ... more details
Drugbox Verifiedfields changed verifiedrevid 458269166 IUPAC name Clinical data tradename pregnancy category legal status investigational routes of administration subcutaneous injection Pharmacokinetic data bioavailability N A metabolism elimination half life excretion Identifiers CAS number Ref cascite changed ?? CAS number 330988 75 5 ATC prefix none ATC suffix PubChem DrugBank Ref drugbankcite correct drugbank DrugBank UNII Ref fdacite correct FDA UNII Q5I7SFZ853 KEGG Ref keggcite correct kegg KEGG D05393 ChemSpiderID Ref chemspidercite correct chemspider ChemSpiderID NA Chemical data C 502 H 758 N 154 O 165 S 16 molecular weight 12,103 g mol protein part Pegsunercept is a pharmaceutical drug drug for the treatment of rheumatoid arthritis . As of 2010 1 , Phase II clinical trial s have been completed. ref ClinicalTrialsGov NCT00037700 Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis ref ref ClinicalTrialsGov NCT00111423 Evaluating the Safety of Extended Treatment With Pegsunercept PEG sTNF RI in Subjects With Rheumatoid Arthritis RA ref ref name Furst pmid 16331754 ref It is being developed by Amgen . Similarly to etanercept , pegsunercept is a soluble CD120 tumor necrosis factor receptor . Pegsunercept is a PEGylated protein. ref name Furst References reflist Immunosuppressants Category TNF alpha inhibitors Category Immunosuppressants antineoplastic drug stub ... more details
6 url ref A third Phase III trial, ACCEPT, compared the efficacy and safety of ustekinumab with etanercept ... author Griffiths C, Strober B, van de Kerkhof P et al. title Comparison of Ustekinumab and Etanercept ... dose etanercept. ref name Griffiths It also demonstrated the clinical benefit of ustekinumab among patients who failed to respond to etanercept. ref name Griffiths Ustekinumab is approved in Canada, Europe ... etanercept and ustekinumab. The entanercept group received subcutaneous injections of the drug twice ... of the low dose ustekinumab group and 74 of the high dose group. Both groups fared better than the etanercept ... more details
neutralizing medication, etanercept Enbrel , is worse than a placebo in Crohn s disease, so TNF ... death of TNF expressing activated T lymphocytes , an important cell type mediating inflammation, but etanercept ... H, van den Brink GR, et al. title Infliximab but not etanercept induces apoptosis in lamina propria ... targeting TNF are golimumab Simponi , adalimumab Humira , and certolizumab pegol Cimzia . Etanercept ... ref Etanercept, a third TNF antagonist, is in a different subclass receptor construct fusion protein , and, because of its modified form, cannot neutralize receptor bound TNF . ref Etanercept product ... lacks this capability. ref Etanercept, Adalimumab and Infliximab product labeling ref Although the clinical ... November 2009 According to the product labeling of infliximab Remicade , etanercept Enbrel , and adalimumab ... suggest infliximab, etanercept, and adalimumab have the potential to reduce the signs ... response to NSAID level 1a, grade A . The anti TNF agents infliximab and etanercept level ... more details
members. Its Product business products include Epogen , darbepoetin Aranesp , Etanercept Enbrel , Anakinra ... for more detail Darbepoetin alfa Aranesp darbepoetin alfa for anemia Etanercept Enbrel Etanercept ... more details
progressive aphasia utilizing perispinal etanercept off label, an anti Tumor necrosis factor ... Tobinick E title Perispinal etanercept produces rapid improvement in primary progressive aphasia identification ... etanercept. http www.brain.northwestern.edu ppa index.html from the Northwestern Cognitive Neurology ... more details
. Treatments directed at tumour necrosis factor Tumor necrosis factors TNF infliximab , etanercept ... necrosis factor alpha and clinical efficacy of the TNF Inhibitor Etanercept in a patient with PAPA syndrome ... more details
Refimprove date March 2009 Infobox disease OMIM 142680 TNF receptor associated periodic syndrome also known as TRAPS , ref name ncbi cite journal author pmc 1235304 title The Tumor Necrosis Factor Receptor Associated Periodic Syndrome New Mutations in TNFRSF1A, Ancestral Origins, Genotype Phenotype Studies, and Evidence for Further Genetic Heterogeneity of Periodic Fevers publisher date ref ref name springerlink Cite web url http www.springerlink.com content 34p7675k44532208 title TNF receptor associated periodic syndrome TRAPS an autosomal dominant multisystem disorder publisher date accessdate 2010 02 02 ref Tumor necrosis factor receptor associated periodic syndrome ref name ncbi or familial Hibernian fever ref name springerlink is a periodic fever syndrome associated with mutations in a receptor biochemistry receptor for the molecule tumor necrosis factors tumor necrosis factor TNF that is inheritable in an autosomal dominant manner. Individuals with TRAPS have episodic symptoms such as recurrent high fevers , rash , abdominal pain , joint muscle aches and puffy eyes. TRAPS was first described in 1982 in a boy of Scottish Irish origin. At that time, it was named familial Hibernian fever. ref name springerlink The main source of TNF tumor necrosis factor is cells in the immune system called macrophage s which produce it in response to infection and other stimuli. TNF helps activate other immune cells and plays a major role in initiation of inflammation . Individuals with TRAPS have a mutation in the CD120 tumor necrosis factor receptor 1 TNFR1 gene . The mechanisms by which mutations in TNFR1 lead to the TRAPS phenotype are still under investigation. Impaired shedding of the TNF receptor is one of the possible defects. Most mutations affect the extracellular domain of the receptor, some also the cleavage site. Citation needed date March 2009 Several medications have been studied for the treatment of TRAPS including etanercept , infliximab , ref Church LD, Churchm ... more details
The BASDAI is important because it is a validated diagnostic test which allows a physician usually a rheumatologist to determine the effectiveness of a current drug therapy, or the need to institute a new drug therapy for the treatment of ankylosing spondylitis . The BASDAI consists of a one through 10 scale measuring discomfort, pain, and fatigue one being no problem and 10 being the worst problem in response to 6 questions pertaining to the 5 major symptoms of Ankylosing Spondylitis AS Fatigue medical Spinal pain Joint pain or swelling Areas of localized tenderness also called enthesitis , or inflammation of tendons and ligaments Morning stiffness duration Morning stiffness severity To give each symptom equal weighting, the average of the two scores relating to morning stiffness is taken. The resulting 0 to 50 score is divided by 5 to give a final 0 10 BASDAI score. Scores of 4 or greater suggest suboptimal control of disease, and patients with scores of 4 or greater are usually good candidates for either a change in their medical therapy, eligible for treatment with powerful biologic therapies such as etanercept , infliximab and adalimumab , or may be eligible for enrollment in clinical trials evaluating new drug therapies directed at Ankylosing Spondylitis. History Garrett and coworkers writing in the http www.ncbi.nlm.nih.gov entrez query.fcgi?cmd Retrieve&db pubmed&dopt Abstract&list uids 7699630 Journal of Rheumatology in December 1994 described a self administered 6 question measurement tool which was to become the gold standard for measuring and evaluating disease activity in Ankylosing Spondylitis AS . This validated tool is the BASDAI, or the Bath Ankylosing Spondylitis Disease Activity Index. A research team consisting of rheumatologist s, physiotherapist s, and research associates with a special interest in AS developed the index in Bath, England , hence the reason for Bath in the name. Validation BASDAI is a quick and simple index taking between 30 sec ... more details
Biological response modifiers , also known as BRM s, are substances that the human body produces naturally, as well as something that scientists can create in a lab. These substances arouse the body s response to an infection. Some of these are used to treat arthritis, cancer, and some other diseases. Biologics include Monoclonal antibodies, Interleukin 2, Interferon, various types of colony stimulating factors CSF, GM CSF, G CSF Immunotherapy makes use of BRMs to enhance the activity of the immune system to increase the body s natural defense mechanisms against cancer ref http www.cancerquest.org index.cfm?page 186 ref whereas BRMs for rheumatoid arthritis aim to reduce inflammation. Some of the effects of BRMs include nausea and vomiting, diarrhea , loss of appetite , fever and chills, muscle aches, weakness, skin rash, an increased tendency to bleed, or swelling. Citation needed date October 2008 Abciximab Mechanism of action A monoclonal antibody that binds to the glycoprotein receptor IIb IIIa on activated platelets, preventing aggregation. Clinical use Acute coronary syndrome s, percutaneous transluminal coronary angioplasty. Toxicity Bleeding, thrombocytopenia . Etanercept Enbrel Mechanism of action Recombinant form of human TNF receptor that binds Tumor necrosis factors TNF . Clinical use Rheumatoid arthritis , psoriasis , ankylosing spondylitis . Infliximab Remicade Mechanism of action A monoclonal antibody to Tumor necrosis factors TNF , proinflammatory cytokine. Clinical use Crohn s disease , rheumatoid arthritis , ankylosing spondylitis . Toxicity Respiratory infection , fever , hypotension . Predisposes to infections reactivation of latent TB . Rituximab Rituxan Mechanism of action A monoclonal antibody to CD20 surface immunoglobulin. Clinical use Lymphoma Trastuzumab Herceptin Mechanism of action A monoclonal antibody against HER2 neu erb B2 . Helps kill breast cancer cells that overexpress HER 2, possibly through antibody dependent cytotoxicity. Clini ... more details
Taxobox color lightgrey name Rothia dentocariosa regnum Bacterium Bacteria phylum classis ordo familia genus Rothia species dentocariosa Rothia dentocariosa is a species of gram positive bacteria gram positive , round to rod shaped bacteria that is part of the normal Oral microbiology community of microbes residing in the mouth and respiratory tract . First isolated from dental caries , Rothia dentocariosa is largely benign, but does very rarely cause disease. The most common Rothia infection is endocarditis , typically in people with underlying heart valve disorders. ref name Ricaurte Cite pmid 11332915 ref Literature case reports show other tissues that are rarely infected include the peritoneum , ref name pmid18159489 cite journal author Morris SK, Nag S, Suh KN, A Evans G title Recurrent chronic ambulatory peritoneal dialysis associated infection due to rothia dentocariosa journal Can J Infect Dis Med Microbiol volume 15 issue 3 pages 171 3 year 2004 month May pmid 18159489 pmc 2094970 doi url ref , tonsils ref name tonsils Cite pmid 15876953 ref , lung ref name Ricaurte , cornea ref name cornea Cite pmid 17133072 ref , inner layers of the eye Endophthalmitis ref name endophthalmitis Cite pmid 11757983 ref and brain and intercranial tissues ref name Ricaurte . It has been implicated in periodontal disease , and one hypothesis is that Rothia periodontal disease, or dental procedures in turn, may be first steps in the infection of other tissues ref name Ricaurte . One case reports on a fatal Rothia dentocariosa infection of a fetus in utero ref name fetalinfection Cite pmid 17980173 ref . Another reports the bacterium was responsible for septic arthritis in the knee of a person treated with etanercept for rheumatoid arthritis . ref name Favero Cite pmid 19966198 ref Like other Rothia infections reported in the literature, once the cause of infection was identified, this responded fully to treatment with antibiotics . Rothia infections may be treated with penicilli ... more details
, infliximab and etanercept , has proven versatile in its effectiveness in treating several conditions ... agents Infliximab Etanercept References Reflist golimumab monthly External links http www.humira.com ... more details
are under investigation to treat Alzheimer s disease. Etanercept A 2006 pilot study showed small ... after treatment with etanercept , a Tumor necrosis factor alpha receptor fusion protein , which binds ... pages 25 year 2006 pmid 16926764 doi pmc 1785182 ref Etanercept was administered by perispinal infusion ... author Griffin WS title Perispinal etanercept potential as an Alzheimer therapeutic journal J Neuroinflammation ... commenced. ref cite journal author Tobinick E title Perispinal etanercept for treatment of Alzheimer ... 18 ref A study published in 2008 of etanercept, administered to a single AD patient via perispinal ... s disease following perispinal etanercept administration journal J. Neuroinflammation volume ... more details
not be used in combination with anti TNF agents such as etanercept Enbrel , infliximab Remicade or adalimumab ... of serious infections and an increased risk of neutropenia have been seen when anakinra and etanercept ... and etanercept did not provide any additional benefit to the patients. Methotrexate Methotrexate has ... more details
List of drugs E Et et eta etacepride International Nonproprietary Name INN etacrynic acid International Nonproprietary Name INN etafedrine International Nonproprietary Name INN etafenone International Nonproprietary Name INN etalocib United States Adopted Name USAN etamicastat International Nonproprietary Name INN etaminile International Nonproprietary Name INN etamiphylline International Nonproprietary Name INN etamivan International Nonproprietary Name INN etamocycline International Nonproprietary Name INN etamsylate International Nonproprietary Name INN etanercept etanidazole International Nonproprietary Name INN etanterol International Nonproprietary Name INN etaqualone International Nonproprietary Name INN etaracizumab United States Adopted Name USAN , International Nonproprietary Name INN etarotene International Nonproprietary Name INN etasuline International Nonproprietary Name INN etazepine International Nonproprietary Name INN etazolate International Nonproprietary Name INN ete etebenecid International Nonproprietary Name INN eterobarb International Nonproprietary Name INN etersalate International Nonproprietary Name INN eth etha ethr ethacridine International Nonproprietary Name INN ethambutol International Nonproprietary Name INN Ethamide Ethamolin ethanol , a type of alcohol ethaverine International Nonproprietary Name INN ethchlorvynol International Nonproprietary Name INN ethenzamide International Nonproprietary Name INN ethinamate International Nonproprietary Name INN ethinylestradiol International Nonproprietary Name INN ethiodized oil 131 I International Nonproprietary Name INN Ethiodol ethionamide International Nonproprietary Name INN ethisterone International Nonproprietary Name INN Ethmozine ethoheptazine International Nonproprietary Name INN ethomoxane International Nonproprietary Name INN ethosuximide International Nonproprietary Name INN ethotoin International Nonproprietary Name INN ethoxazorutoside International Nonproprietary Name INN Ethra ... more details
of IBD. These include etanercept which is the soluble Receptor immunology receptor for tumor necrosis factors TNF . ref name Etanercept cite journal author Sandborn W, Hanauer S, Katz S, Safdi M, Wolf D, Baerg R, Tremaine W, Johnson T, Diehl N, Zinsmeister A title Etanercept for active Crohn s disease ... more details
Encyclopedia
top
